top of page

AI Pharma Business Intelligence, Investor Relations, Business Development Operational Environment Big Data Analytics Dashboard

End-to-end solution for AI Pharma-focused corporate strategy optimization and defence, semi-automated AI-driven business development, investor relations, partnership and client acquisition and corporate growth, competitive and market intelligence, and operational environment monitoring, forecasting and analytics. 

Project Overview

Informational Overview

a2.png

Other Deep Pharma Intelligence Products

s3.png

Deep Pharma Intelligence (DPI)’s AI Pharma Business Intelligence, Investor Relations, Business Development Operational Environment Big Data Analytics Dashboard constitutes and end-to-end solution for AI Pharma-focused corporate strategy optimization and defence, semi-automated AI-driven business development, investor relations, partnership and client acquisition and corporate growth, competitive intelligence, operational environment monitoring and analytics 

Component 1: DPI Big Data Analytics Market Intelligence System Dashboard Subscription
Component 2: Custom AI-Driven Market Intelligence Big Data Analytics Dashboard Development
Component 3: Complex Operational Environment Mapping
Component 4: Tailored Market Intelligence, SWOT and competitive analysis

z1.png

Component 1: DPI Big Data Analytics Market Intelligence System Dashboard Subscription

​

  1. Clinical and Preclinical Insights: Access expansive datasets on clinical trials and preclinical research, crucial for advancing R&D and staying ahead of industry trends.

  2. Automated SWOT Analysis: Utilize AI-driven SWOT analysis for a comprehensive understanding of your corporation's strategic position within the pharmaceutical landscape.

  3. Market Projections: Benefit from predictive market projections to guide long-term strategic planning and investment decisions.

  4. Competitive Landscape Overview: Gain an edge with automated competitive analysis, identifying key market players and strategic opportunities.

  5. Investor and Collaboration Matching: Leverage matching tools to connect with potential investors and collaborators, enhancing your corporation's network and strategic partnerships.

z2.png
z3.png

Component 2:  Custom AI-Driven Market Intelligence Big Data Analytics Dashboard Development

​

  1. Custom Configuration: We construct a dashboard that is the epitome of bespoke design, built to integrate seamlessly with client’s unique strategic and operational frameworks.

  2. Comprehensive Toolkit: clients have the autonomy to select from our expansive range of analytical tools and data sets, ensuring that every element of the dashboard is meticulously curated to serve their distinct purposes.

  3. Diverse Applications: The dashboard is versatile, crafted to support a multitude of use cases from granular market analysis to macro-level strategic planning, providing the client with the agility to address various business challenges.

  4. Control and Oversight: the client maintains full control over the dashboard's scope, functionalities, and deployment, ensuring that the final product is an authentic reflection of their strategic vision.

  5. White Label Solution: Upholding the essence of brand consistency, the dashboard is developed as a white label solution, allowing clients to brand and present the analytical platform as their own proprietary technology.

  6. Ongoing Evolution: Recognizing the dynamic nature of the pharmaceutical industry, the dashboard is designed for scalability and adaptability, accommodating future expansions and refinements.

z4.png
z5.png

Component 3: Complex Operational Environment Mapping

​

Deep Pharma Intelligence’s Complex Operational Environment Mapping is an advanced analytical offering designed to provide clients with a multifaceted view of the pharmaceutical industry's operational landscape. Through a combination of AI-driven technologies and data analysis methodologies, this component offers a strategic edge in understanding and navigating the market.

  1. Operational Environment Mapping: Utilizing AI algorithms and deep neural networks, we provide a high-definition map of the industry's operational environment, pinpointing key players, market dynamics, and growth opportunities.

  2. Cross-Industrial Comparative Analysis: Our tools perform a comparative analysis across industries, revealing insights into how the client can leverage cross-sectoral strategies and innovations.

  3. Automated Comparative Analysis & Multidimensional Vector Space Analysis: By comparing entities on a multitude of factors, we assist  clients in understanding their position relative to competitors and potential partners.

  4. Trading Recommendation System: This system leverages market data and trends to offer the client with actionable trading insights, enabling informed investment decisions.

  5. AI-based Smart Matching System: At the heart of our offering is the Smart Matching System, which uses quantifiable SWOT analysis to identify and recommend optimal partnership opportunities, tailored to align with the client’s strategic objectives.

  6. Technology Forecasting for Business Development and M&A: Our predictive models forecast technological advancements, assisting the client in identifying M&A opportunities and guiding R&D investments.

  7. Partnership Recommendation System: Our AI-driven recommendation engine can form strategic alliances, maximizing the potential for innovation and market impact.

z6.png
z7.png

Component 4: Tailored Market Intelligence, SWOT and competitive analysis

​

  1. Precise Entities Analysis and Evaluation: Dive deep into individual entities within the pharmaceutical sector, offering comprehensive analysis and evaluation to inform strategic decisions.

  2. Cross-Industrial Comparative Analysis: Leverage our capabilities to perform cross-industrial comparisons, identifying unique opportunities and challenges within and beyond the pharmaceutical industry.

  3. Comparative Analysis: Utilize advanced tools for comparative analysis, enabling the client } to understand its competitive position in relation to key market players.

  4. Entities Classification and Assessment: Benefit from our sophisticated classification and assessment methodologies, categorizing entities based on various strategic dimensions to highlight potential opportunities and risks.

  5. Multimodal SWOT Analysis: Explore a comprehensive SWOT analysis covering over 100 parameters, providing a multifaceted view of strengths, weaknesses, opportunities, and threats in unprecedented detail.

  6. TRL (Technology Readiness Level) Evaluations: Gain insights into the maturity and readiness levels of technologies within the pharmaceutical sector, aiding in strategic planning and innovation management.

  7. Additional Features: Access a variety of other features designed to enhance market 

bottom of page